Home › Compare › MEDVi vs Willow

MEDVi vs Willow: Price, Yearly Cost & Cancellation

Researched by GLPHunter · Prices verified October 16, 2026 · Sources · We may earn a commission

The short version

On the most flexible semaglutide plans, MEDVi costs $120 less over a year ($3,468 vs $3,588). MEDVi charges no membership fee; Willow charges no membership fee. Prices verified October 16, 2026.

Side by side

	MEDVi	Willow
Semaglutide, most flexible plan	$299/mo (first month $179)	$299/mo
Semaglutide, lowest rate	$299/mo (monthly, no contract)	$299/mo (monthly subscription)
Semaglutide, first year	$3,468	$3,588
Membership fee	None	None
Higher doses	Not stated beyond refills being 'locked in' at $299 for semaglutide.	Possible: terms say the Subscription Fee may be increased or decreased if the prescription changes, 'such as by a dosage increase', with disclosure and consent before charging.
Consultation	Online intake screened against OpenLoop Health criteria, then an OpenLoop clinician meets with the patient after checkout; refund FAQ mentions live and electronic consultations.	Online assessment reviewed by physicians of Willow's affiliated medical practice; same-day prescriptions advertised; unlimited physician access and 24/7 care team. Visit format not specified.
States	Not published	Not published
How to cancel	Email hello@medvi.org or use chat in the patient portal, at least 72 hours before the next billing date.	FAQ: message the Patient Care Team; terms: log into the account page at StartWillow.com.
Refunds	Full refund if cancelled within 72 hours of the term with no services received, or if medically disqualified. Monthly plans: no refund for the current or prior months. Multi-month plans: refund for months with no medication shipped.	Full refund within 5-10 business days if canceled before the prescription is sent to the pharmacy; otherwise charges are non-refundable once incurred (per terms, subject to the Subscription and Return Policies).
Trustpilot	4.3 (15,026 reviews)	4.0 (373 reviews)
Regulatory notes	FDA warning letter dated Feb 20, 2026 (posted Mar 3, 2026) to MEDVi, LLC for false or misleading claims about compounded semaglutide/tirzepatide, including product images suggesting MEDVi is the compounder.; California class action filed March 20, 2026 (case 8:2026cv00641) alleging MEDVi benefited from deceptive affiliate spam emails; Moneywise also reports a data-privacy class action and a Sept 2025 request by consumer groups for an FTC investigation.	Eli Lilly sued Willow Health Services (April 2025) alleging false claims about compounded tirzepatide, including marketing a 'cosmetic' GLP-1; a federal judge dismissed the suit in September 2025, finding Lilly had not shown patients or physicians switched to the compounded product.; News coverage of the Lilly lawsuit naming Willow Health.

First-year cost uses each provider's most flexible plan (month-to-month where offered), including any intro month and membership fee. Prepaid plans cost less per month but are harder to exit.